Related Experiment Videos
Mast cells, eosinophils and fibrosis
1Department of Pharmacology, School of Pharmacy, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Abstract:
We have presented results that increase our understanding of the roles MC and EOS play in modulating fibrotic processes. In vitro studies have provided clear-cut evidence for the direct involvement of these two inflammatory cells in enhancing proliferation, and either enhancing or decreasing collagen synthesis in human fibroblasts isolated from different anatomical locations. In addition, we have shown that MC and EOS interactions can also take part in modulating fibrosis. In vivo studies in murine and human cGVHD showed that MC activation is detrimental, and that MC stabilization therapy may be helpful in treating the fibrotic outcome of this disease. Much is still obscure. It is, for example, important to define the MC and EOS mediators involved in the modulation of fibroblast properties, and their pattern of influence, keeping in mind the ultimate goal of defining new therapeutic targets for the treatment of fibrotic diseases.
Insights
Mast cells (MC) and eosinophils (EOS) directly impact fibrotic processes by influencing fibroblast proliferation and collagen synthesis. MC activation in chronic graft-versus-host disease (cGVHD) is harmful, suggesting MC stabilization as a potential therapy.
Area of Science:
- Immunology
- Cell Biology
- Fibrosis Research
Background:
- Fibrotic diseases are characterized by excessive collagen deposition and tissue remodeling.
- The roles of mast cells (MC) and eosinophils (EOS) in modulating fibrosis remain incompletely understood.
- Inflammatory cell involvement in fibroblast behavior is crucial for understanding fibrotic pathogenesis.
Purpose of the Study:
- To elucidate the specific roles of MC and EOS in modulating fibrotic processes.
- To investigate the impact of MC and EOS interactions on human fibroblast properties.
- To evaluate the therapeutic potential of MC stabilization in fibrotic conditions like cGVHD.
Main Methods:
- In vitro studies using human fibroblasts from various anatomical locations.
- In vivo studies in murine and human chronic graft-versus-host disease (cGVHD) models.
- Assessment of fibroblast proliferation and collagen synthesis modulated by MC and EOS.
Main Results:
- MC and EOS directly enhance fibroblast proliferation and differentially regulate collagen synthesis in vitro.
- Interactions between MC and EOS significantly modulate fibrotic processes.
- MC activation is detrimental in vivo in cGVHD models, indicating a pro-fibrotic role.
Conclusions:
- MC and EOS are key modulators of fibrotic processes, influencing fibroblast behavior.
- MC activation contributes to fibrosis in cGVHD, suggesting MC stabilization as a therapeutic strategy.
- Further research is needed to identify specific mediators and therapeutic targets for fibrotic diseases.